| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
July 27, 2004 |
|
|
| |
|
|
| |
|
|
|
Strategic Research Institute, The Westin Princeton at Forrestal Village
09/20/2004-09/21/2004
The Pharma and Biotech Business intelligence summit will explore professional and academic advancement in the CI field. Some of the key issues to be addressed in this year’s forum include:Business Intelligence in R&D Strategy: Provider and Customer Perspectives;
Cost Effective CI: Making an Omelet Without Breaking Any Eggs;
The Global CI Challenge;
Analyzing Competitor Technical Capabilities For Enhanced Strategic Positioning;
Government & Regulatory Influence on Pharma & CI;
Medical Conference Intelligence Collection Process;
The Development of Effective Ongoing Pipeline Assessment;
Business Intelligence…….A Project Or A System?;
Information Resources to Competitive Analysis: The Story of a Group Who Made the Transition;
Core Competencies & Best Practices for the Pharma CI Practitioner;
How to Perfect CI Performance & The Current Status of the CI Profession;
Application Of Business Intelligence To Set R&D Priorities
|
|
|
|
|
|
|
|
Organized by:
|
|
Strategic Research Institute |
|
|
Invited Speakers:
|
|
Clifford C. Kalb,
Former Senior Diector, Strategic Business Analysis
MERCK & CO., INC.Dr. Daniel Pascheles
Vice President & Head of Corporate CI
AVENTIS PHARMA and many more executives from the pharma, biotech, and business industries
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
09/20/2004
|
|
|
|
|
|
|
|
Registration:
|
|
$1,195.00: Early-bird rate for Delegates
(offer ends August 15, 2004 : will be $1395 thereafter)
|
|
|
E-mail:
|
|
info@srinstitute.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|